Cargando…

Mitochondria dysregulation contributes to secondary neurodegeneration progression post-contusion injury in human 3D in vitro triculture brain tissue model

Traumatic Brain injury-induced disturbances in mitochondrial fission-and-fusion dynamics have been linked to the onset and propagation of neuroinflammation and neurodegeneration. However, cell-type-specific contributions and crosstalk between neurons, microglia, and astrocytes in mitochondria-driven...

Descripción completa

Detalles Bibliográficos
Autores principales: Liaudanskaya, Volha, Fiore, Nicholas J., Zhang, Yang, Milton, Yuka, Kelly, Marilyn F., Coe, Marly, Barreiro, Ariana, Rose, Victoria K., Shapiro, Matthew R., Mullis, Adam S., Shevzov-Zebrun, Anna, Blurton-Jones, Mathew, Whalen, Michael J., Symes, Aviva J., Georgakoudi, Irene, Nieland, Thomas J. F., Kaplan, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400598/
https://www.ncbi.nlm.nih.gov/pubmed/37537168
http://dx.doi.org/10.1038/s41419-023-05980-0
Descripción
Sumario:Traumatic Brain injury-induced disturbances in mitochondrial fission-and-fusion dynamics have been linked to the onset and propagation of neuroinflammation and neurodegeneration. However, cell-type-specific contributions and crosstalk between neurons, microglia, and astrocytes in mitochondria-driven neurodegeneration after brain injury remain undefined. We developed a human three-dimensional in vitro triculture tissue model of a contusion injury composed of neurons, microglia, and astrocytes and examined the contributions of mitochondrial dysregulation to neuroinflammation and progression of injury-induced neurodegeneration. Pharmacological studies presented here suggest that fragmented mitochondria released by microglia are a key contributor to secondary neuronal damage progression after contusion injury, a pathway that requires astrocyte-microglia crosstalk. Controlling mitochondrial dysfunction thus offers an exciting option for developing therapies for TBI patients.